By: Nicole McLaren
In the past two weeks the Trump administration has dominated the news, some of this has been about the nominations he has made for leadership positions in the executive branch. He has nominated Tom Price for Health and Human Services. This nomination could have a direct impact on access to healthcare services and could dis-proportionally affect women and others who have benefited from the Affordable Care Act.
Tom Price is a congressman for Georgia’s 6th congressional district. During his time in Congress he sponsored bills that attempt to dismantle federal funding for healthcare services and he has spent years attempting to get rid of the Affordable Care Act. There is also speculation that he used his power as a US representative to benefit a health company that he owns stock in. The bill reversed cuts in reimbursements to the company. Since 2012 he has traded about $300,000 worth of shares in almost 40 different health companies. He has directly benefited from the rising cost of health care in the US which poses a problem if he is going to be the leader of Health and Human Services.
He will now be in a place of power to directly influence healthcare in the US if he is confirmed as the head of Health and Human Services. This nomination could have direct impact on the access to affordable healthcare. The ability to access healthcare services including reproductive and preventative healthcare is extremely important. For women to be able to participate in society we must have access to these services so that we have a choice and a say in our futures.
It is also important to think about the impact this will have on women who need access to reproductive healthcare through Planned Parenthood and how funding for Health and Human Services could hurt the ability to access these things. Healthcare is a fundamental right for all people and we have to work to make that a reality.